Vacinas

Análise mostra que os benefícios da vacinação contra COVID-19 pesam mais que os riscos de raros casos de miocardite.

22 Jul, 2021 | 13:04h

Comunicado de imprensa: Study finds benefits of COVID-19 vaccination outweigh risks of rare cases of myocarditis – American Heart Association

Estudo original: Myocarditis with COVID-19 mRNA Vaccines – Circulation

Comentário: Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns – TCTMD

Comentário no Twitter

Just published ahead of print- Myocarditis with Covid mRNA Vaccines https://t.co/mc2yrr5pDV Mechanisms, benefit of COVID-19 mRNA vaccination over low risk, management strategies – review of all myocarditis cases published to date, CDC&other reports @PeterHotez @ishannovation

— BiykemBozkurt (@BiykemB) July 20, 2021

Opinião | Os benefícios da vacina contra COVID superam muito os pequenos riscos de inflamação cardíaca tratável.

22 Jul, 2021 | 13:03h

The benefits of a COVID vaccine far outweigh the small risk of treatable heart inflammation – The Conversation

OMS e Unicef alertam para o declínio nas vacinações durante a pandemia de COVID-19.

20 Jul, 2021 | 10:57h

WHO and UNICEF warn of a decline in vaccinations during COVID-19 – World Health Organization

Ver também: COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows – World Health Organization

Relacionado: Millions of children worldwide missed routine vaccinations during the pandemic, study suggests.

Avaliação da cobertura vacinal de crianças de 204 países e territórios, 1980-2019: análise sistemática para o Global Burden of Disease Study 2020.

20 Jul, 2021 | 10:42h

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 – The Lancet

Relacionado: Millions of children worldwide missed routine vaccinations during the pandemic, study suggests.

CDC alerta que as vacinas contra Covid-19 podem não proteger pessoas imunocomprometidas – “O CDC está investigando pesquisas em andamento sobre a possibilidade de pacientes imunocomprometidos terem benefício com uma dose adicional.”

19 Jul, 2021 | 09:59h

CDC warns Covid-19 vaccines might not protect people who are immunocompromised – CNN

Estudo sugere que milhões de crianças pelo mundo interromperam as rotinas de vacinação durante a pandemia.

15 Jul, 2021 | 10:40h

Millions of children worldwide missed routine vaccinations during the pandemic, study suggests – CNN

Estudo original: Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study – The Lancet

Comentário convidado: Disruptions to childhood immunisation due to the COVID-19 pandemic – The Lancet

Estudo de coorte | Vacina da Pfizer/BioNTech contra COVID está associada com 78% menos risco de ocorrência de Covid-19 durante a gestação.

14 Jul, 2021 | 11:45h

Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women – JAMA

Comentário: Pfizer COVID vaccine shows 78% efficacy in pregnancy – CIDRAP

Dois estudos mostram que 1 dose de vacina contra COVID rende boa proteção em idosos.

14 Jul, 2021 | 11:40h

One COVID vaccine dose yields good protection in elderly, 2 studies find – CIDRAP

Estudo original 1: Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study – The Lancet Infectious Diseases

Estudo original 2: Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study – The Lancet Infectious Diseases

Comentário no Twitter (fio – clique para saber mais)

2 research Articles on #COVID19 vaccine effectiveness in older people:
1) Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study https://t.co/ELvMCPwSHF

— The Lancet Infectious Diseases (@TheLancetInfDis) June 24, 2021

Casos extremamente raros de Guillain-Barré relatados com a vacina da Johnson & Johnson contra a Covid-19.

13 Jul, 2021 | 11:24h

J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says – STAT

Ver também: Johnson & Johnson Vaccine Is Linked To Neurological Disorder In Extremely Rare Cases – NPR E F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine – The New York Times

Sensibilidade reduzida da variante Delta do SARS-CoV-2 a neutralização por anticorpos.

9 Jul, 2021 | 16:04h

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization – Nature

Comentários: Study highlights need for full Covid vaccination to protect against Delta variant – STAT E How does the Delta variant dodge the immune system? Scientists find clues. – The New York Times